ArticleJournal of hepatocellular carcinoma2019

Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve.

Nicholas Fidelman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.